Regulators commonly require enhanced anti-money laundering controls such as increased staff training and program improvements as corrective measures in gambling industry enforcement settlements.
November 21, 2025
high
procedural
Typical remedial actions imposed by gaming regulators following AML compliance failures.
Regulators and child-safety advocates warn that releasing online products rapidly without adequate guardrails can recreate harms seen with social media.
November 07, 2025
high
trend
General policy concern about rapid product launches in tech and potential harms to users.
An early 2000s female-designated crash test dummy used in some regulatory tests was a scaled-down version of a male dummy with breasts added and did not capture true anatomical differences between typical male and female bodies.
2000s
high
descriptive
This design approach has been criticized for failing to represent female pelvic, neck, and limb anatomy that affect injury outcomes in crashes.
Employers and regulators often discourage workers in safety-sensitive roles, including air traffic controllers, from taking second jobs in order to avoid distractions and maintain operational safety.
high
policy
Workplace and regulatory practice aimed at preserving safety in critical occupations.
Increased local electricity demand from large facilities such as data centers can contribute to higher retail energy prices for customers if utilities or regulators allow cost pass-throughs for new infrastructure or fuel expenses.
high
causal
Higher demand can require new transmission or generation investments and increase fuel procurement, and regulatory decisions determine how those costs are allocated to customers.
Vaccines undergo evaluation before being added to immunization schedules and are continually monitored by researchers and regulators after implementation.
high
process
Describes the standard regulatory and surveillance processes applied to vaccines.
Because biologic drugs are large molecules produced from live cells, biosimilar copies cannot be chemically identical; as a result, regulators historically required clinical studies for biosimilars, and research indicates that advanced analytical techniques can sometimes substitute for large clinical trials to show no clinically meaningful differences.
high
scientific
Scientific basis for regulatory approaches to demonstrating biosimilarity.